Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 4/20 cls
Genzyme (GENZ) Fortis Geraldine O'Keeffe New Buy 1% $63.22
O'Keeffe set a $74 target. She noted GENZ expects results this year from Phase III trials of tolevamer to treat Clostridium difficile-associated diarrhea and Mozobil to treat multiple myeloma and

Read the full 521 word article

How to gain access

Continue reading with a
two-week free trial.